Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1381621

O=C(O)C(F)(F)F.O=S(=O)(Nc1cc2cccnc2c(N2CCNCC2)n1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 6/20 0.52
▸ HTR6 P50406 3/20 0.45
▸ CKS1B P61024 2/20 0.45
▸ SKP2 Q13309 2/20 0.45
▸ HSD11B1 P28845 1/20 0.43
▸ CLK1 P49759 1/20 0.43
▸ RAD52 P43351 1/20 0.43
▸ UBE2N P61088 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TSHR P16473 1/20 0.41
▸ F2 P00734 1/20 0.41
▸ PKLR P30613 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PRKD1 Q15139 1/20 0.39
▸ KDM1A O60341 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3623702 0.95 SLC40A1 (0.58) SLC40A1HTR6CKS1BSKP2HSD11B1
Trifluoroacetic Acid SCHEMBL1380515 0.87 RAD52 (0.43) SLC40A1RAD52UBE2NL3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL1379813 0.85 HTR6 (0.47) HTR6MEN1GAAKMT2A
Trifluoroacetic Acid SCHEMBL1380631 0.85 HTR6 (0.45) SLC40A1HTR6HSD11B1RAD52UBE2N
SCHEMBL7045097 0.84 SLC40A1 (0.49) SLC40A1HTR6PRKD1
Trifluoroacetic Acid SCHEMBL6047104 0.82 SLC40A1 (0.47) SLC40A1HTR6HSD11B1RAD52UBE2N
Trifluoroacetic Acid SCHEMBL1380171 0.80 L3MBTL1 (0.43) HTR6RAD52UBE2NL3MBTL1PRKD1
SCHEMBL1379328 0.78 TDP1 (0.50) SLC40A1HTR6CKS1BSKP2L3MBTL1
SCHEMBL3616470 0.78 MEN1 (0.50) SLC40A1HTR6L3MBTL1MEN1KMT2A
SCHEMBL1381623 0.77 HTR6 (0.41) SLC40A1HTR6HSD11B1RAD52UBE2N

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4731114-B2 — — 2011-07-20 — — JP claimed
EP-1412325-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS, PROCESS FOR THEIR USE AS MEDICAMENT FOR THE TREATMENT OF CNS DISORDERS, OBESITY AND TYPE II DIABETES BIOVITRUM AB (SE) 2004-04-28 — — EP claimed
WO-2002100822-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS, PROCESS FOR THEIR USE AS MEDICAMENT FOR THE TREATMENT OF CNS DISORDERS, OBESITY AND TYPE II DIABETES BIOVITRUM AB (SE) 2002-12-19 — — WO claimed
US-7144883-B2 Bicyclic sulfonamide compounds BIOVITRUM AB (SE) 2006-12-05 — — US disclosed
Send feedback